
Sagimet Biosciences Inc.
SGMTNasdaqCIK 1400118HealthcareFiscal year ends Dec 31
Reports and events: 79 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-05-2307:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-064509 |
| 2024-05-1508:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-061609 |
| 2024-05-1507:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-008205 |
| 2024-05-0608:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-057228 |
| 2024-04-1806:16 ET | DEF 14A | Proxy statementPeriod 2024-06-05 | 0001104659-24-048534 |
| 2024-03-2506:37 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-003812 |
| 2024-03-2506:19 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-038101 |
| 2024-02-0216:36 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-010085 |
| 2024-01-3016:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-008230 |
| 2024-01-2406:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-006042 |
| 2024-01-2406:08 ET | S-1/A | Registration statement, amended | 0001104659-24-006039 |
| 2024-01-2317:31 ET | S-1 | Registration statement | 0001104659-24-005946 |
| 2024-01-2208:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-005399 |
| 2023-12-2916:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-130486 |
| 2023-11-2116:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-23-120365 |
| 2023-11-1308:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-116795 |
| 2023-11-1308:31 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001558370-23-018700 |
| 2023-10-2308:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-110654 |
| 2023-09-2716:32 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-104304 |
| 2023-08-2116:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-093921 |
| 2023-08-2116:05 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001104659-23-093910 |
| 2023-08-1008:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-089579 |
| 2023-07-2716:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-23-084764 |
| 2023-07-1816:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-23-082006 |
| 2023-07-1006:04 ET | S-1/A | Registration statement, amended | 0001104659-23-079261 |
| 2023-07-0316:08 ET | S-1/A | Registration statement, amended | 0001104659-23-077601 |
| 2023-06-2317:03 ET | S-1 | Registration statement | 0001104659-23-074215 |
| 2021-05-1017:26 ET | S-1/A | Registration statement, amended | 0001104659-21-064037 |
| 2021-04-1616:31 ET | S-1 | Registration statement | 0001104659-21-051413 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 15, 2026, 02:25 ET. Listed shows no prices and gives no investment advice.